Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

On November 15, 2021 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that members of the senior management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, taking place on Monday, November 29 – Thursday, December 2, 2021 (Press release, Leap Therapeutics, NOV 15, 2021, View Source [SID1234595631]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A replay of the pre-recorded fireside chat can be accessed on Monday, November 22, 2021 at 10:00 a.m. eastern time on the Investors page of the company’s website at View Source, where a replay of the event will also be available for a limited time.